Standard Diagnostic, Inc.(SD) is a worldwide leader in the development and commercialization of innovative technology-based products for Human. located in Suwon city, Kyonggi province, Korea. SD conducts operations in 95 countries around the world and employs over 100 peoples in full-and part-time positions in Korea.

SD's primary business focuses on human health, a growing market around the world. In this market, SD develops, produces and sells an integrated portfolio of products and services to clinical laboratory. Offerings include in-clinic diagnostic tests and instrumentation and practice
Over 10 scientists drive innovation, identifying relevant new technologies and developing them for clinical diagnostic application. The mission of this business is to supply Physician, Laboratory technicians with tools, technologies and services that support best medical practices, enabling physicians, laboratory technician to respond to the health needs of their patients, while operating more efficient and profitable practices.

SD leverages its expertise in diagnostic technology in three additional business areas. Standard Diagnostic, Inc.(SD) offers wide rage of rapid immunodiagnostic products for point-of-care testing of infectious disease, fertility, drug abuse, tumor marker, drug of abuse, cardiac makers, bioterror and ELISA kit and Urine Chemistry system and the total technology including the development from recombinant antigen, monoclonal antibody and gold conjugate to final rapid kit/ELISA kit
Ongoing research and development plays an important role in creating the technology to meet our customer needs. SD has been consistently developing new products through its own qualified R&D activities.

These products are scaled-up at the latest state-of-the art manufacturing facility under certified Quality Management Systems that confirms to the International Standards (ISO13485:2003) and maintained under the high standard of Quality Assurance.